Sorry, you need to enable JavaScript to visit this website.
icone
Obesity

Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.

Supporting weight management following GLP-1 de-prescription

Supporting weight management following GLP-1 de-prescription

One challenge that arises after the completion of any weight loss therapy is weight regain. OPTIFAST VLCD products can be beneficial to help individuals maintain nutritional balance and reduce overall caloric intake to support continued weight management.